Try our Advanced Search for more refined results
- Law360
- Law360 UK
- Law360 Pulse
- Law360 Employment Authority
- Law360 Tax Authority
- Law360 Insurance Authority
- Law360 Real Estate Authority
- Law360 Healthcare Authority
- Law360 Bankruptcy Authority
- Products
- Lexis®
- Law360 In-Depth
- Law360 Podcasts
- Rankings
- Leaderboard Analytics
- Regional Powerhouses
- Law360's MVPs
- Women in Law Report
- Law360 400
- Diversity Snapshot
- Practice Groups of the Year
- Rising Stars
- Titans of the Plaintiffs Bar
- Sections
- Adv. Search & Platform Tools
- About all sections
- Browse all sections
- Banking
- Bankruptcy
- Class Action
- Competition
- Employment
- Energy
- Expert Analysis
- Insurance
- Intellectual Property
- Product Liability
- Securities
- Beta Tools
- Track docs
- Track attorneys
- Track judges
In Re: Armodafinil Patent Litigation
Case Number:
1:10-md-02200
Court:
Nature of Suit:
Multi Party Litigation:
Multi-district Litigation
Judge:
Firms
- Bloom & Bloom LLC
- Buchanan Ingersoll
- Carlton Fields
- Connolly Gallagher
- Heyman Enerio
- Katten Muchin
- Nelson Mullins
- Phillips McLaughlin
- Potter Anderson
- Shaw Keller
- Smith Katzenstein
- Womble Bond
- Young Conaway
Companies
- Allergan PLC
- Apotex Inc.
- Cephalon Inc.
- Sandoz International GmbH
- Teva Pharmaceutical Industries Ltd.
- Viatris Inc.
Sectors & Industries:
-
April 01, 2013
Cephalon Beats Challenge To Narcolepsy Drug Patent
A Delaware federal judge on Saturday handed a win to Cephalon Inc. in its patent infringement suit aiming to block the sale of generic versions of the narcolepsy drug Nuvigil, rejecting generic-drug makers' claims that Cephalon's patent on the drug was invalid.
-
July 18, 2012
Cephalon Defends Narcolepsy Drug From Generics At Trial
Cephalon Inc. squared off with a host of generic-drug makers in Delaware federal court on Wednesday in a patent infringement suit aiming to block generic versions of its narcolepsy drug Nuvigil from hitting the market.
-
May 11, 2011
Cephalon Drops Nuvigil Patent Suit Against Teva
Cephalon Inc. dropped its patent infringement suit in Delaware against Teva Pharmaceuticals USA Inc. on Wednesday, resolving one of several cases in a multidistrict litigation over the narcolepsy drug Nuvigil.